Lifestyle changes in women with polycystic ovary syndrome

Cochrane Database of Systematic Reviews

Volumn 2019, Issue 3, 2019, Pages

  Lim, Siew S ^a   Hutchison, Samantha K ^a,b   Van Ryswyk, Emer ^c   Norman, Robert J ^d,e   Teede, Helena J ^a   Moran, Lisa J ^a  

^a MONASH UNIVERSITY   (Australia)

^b SOUTHERN HEALTH   (Australia)

^c FLINDERS UNIVERSITY   (Australia)

^d UNIVERSITY OF ADELAIDE   (Australia)

^e Fertility SA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BEHAVIOR THERAPY; BODY COMPOSITION; BODY MASS; BODY WEIGHT; BODY WEIGHT LOSS; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CLINICAL OUTCOME; DIET THERAPY; FEMALE FERTILITY; FREE ANDROGEN INDEX; HUMAN; INTERMETHOD COMPARISON; KINESIOTHERAPY; LIFESTYLE MODIFICATION; MENSTRUATION DISORDER; METABOLISM; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPRODUCTION; REVIEW; SPONTANEOUS ABORTION; SYSTEMATIC REVIEW; UNCERTAINTY; ABDOMINAL FAT; ANATOMY AND HISTOLOGY; COMPLICATION; EXERCISE; FEMALE; GONADAL DISEASE; INSULIN RESISTANCE; LIFESTYLE; META ANALYSIS; OBESITY; WAIST CIRCUMFERENCE;

ABDOMINAL FAT; EXERCISE; FEMALE; HUMANS; INSULIN RESISTANCE; LIFE STYLE; OBESITY; POLYCYSTIC OVARY SYNDROME; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VIRILISM; WAIST CIRCUMFERENCE; WEIGHT LOSS;

EID: 84901978468     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD007506.pub4     Document Type: Review

References (134)

1. Almenning I, Rieber-Mohn A, Lundgren KM, Shetelig Løvvik T, Garnæs KK, Moholdt T,. Effects of high intensity interval training and strength training on metabolic, cardiovascular and hormonal outcomes in women with polycystic ovary syndrome: a pilot study. PloS One 2015; 10 (9): e0138793. 10544611
2. Brown AJ, Setji TL, Sanders LL, Lowry KP, Otvos JD, Kraus WE, et al., Effects of exercise on lipoprotein particles in women with polycystic ovary syndrome. Medicine and Sciences in Sports and Exercise 2009; 41 (3): 497 - 504. 3337395
3. Guzick DS, Wing R, Smith D, Berga SL, Winters SJ,. Endocrine consequences of weight loss in obese, hyperandrogenic, anovulatory women. Fertility and Sterility 1994; 61 (4): 598 - 604. 3337397
4. Hoeger KM, Kochman L, Wixom N, Craig K, Miller RK, Guzick DS,. A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study. Fertility and Sterility 2004; 82 (2): 421 - 9. 3337399
5. Hoeger K, Davidson K, Kochman L, Cherry T, Kopin L, Guzick DS,. The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials. Journal of Clinical Endocrinology and Metabolism 2008; 93 (11): 4299 - 306. 3337401
6. Mani H, Chudasama Y, Hadjiconstantinou M, Bodicoat DH, Edwardson C, Levy MJ, et al., Structured education programme for women with polycystic ovary syndrome: a randomised controlled trial. Endocrine Connections 2018; 7 (1): 26 - 35. 10544613
7. Mirfeizi M,. Comparison of effects of diet and exercise program to improve clinical symptoms and laboratory tests in obese women with polycystic ovary syndrome (PCOS). Medical Journal of Mashhad University of Medical Sciences 2013; 56 (2): 77 - 84. 10544615
8. Nasrekani ZA, Fathi M,. Efficacy of 12 weeks aerobic training on body composition, aerobic power and some women-hormones in polycystic ovary syndrome infertile women. Iranian Journal of Obstetrics, Gynecology and Infertility 2016; 19 (5): 1 - 10. 10544617
9. Saremi A, Nader, Karmali M, Kazemi M,. Serum level of anti-mullerian hormone after exercise training in women with polycystic ovary syndrome: a randomised controlled trial. Iranian Journal of Obstetrics, Gynecology and Infertility 2013; 16 (64): 10. 10544619
10. Saremi A, Yaghoubi MS,. Effect of resistance exercises with calcium consumption on level of anti-mullerian hormone and some metabolic indices in women with polycystic ovarian syndrome. Iranian Journal of Obstetrics, Gynecology and Infertility 2016; 18 (180): 7 - 15. 10544621
11. Stefanaki C, Bacopoulou F, Livadas S, Kandaraki A, Karacalios A, Chrousos G, et al., Impact of a mindfulness stress management program on stress, anxiety, depression and quality of life in women with polycystic ovary syndrome: a randomised controlled trial. Stress (Amsterdam, Netherlands) 2015; 18 (1): 57 - 66. 10544623
12. Jedel E, Labrie F, Oden A, Holm G, Nilsson L, Janson PO, et al., Impact of electro-acupuncture and physical exercise on hyperandrogenism and oligo/amenorrhea in women with polycystic ovary syndrome: a randomised controlled trial. American Journal of Physiology-Endocrinology and Metabolism 2011; 300 (1): E37 - 45. 10544625
13. Leonhardt H, Hellstrom M, Gull B, Lind AK, Nilsson L, Janson OP, et al., Serum anti-Mullerian hormone and ovarian morphology assessed by magnetic resonance imaging in response to acupuncture and exercise in women with polycystic ovary syndrome: secondary analyses of a randomized controlled trial. Acta Obstetricia et Gynecologica Scandinavica 2015; 94: 279 - 87. 10544626
14. Stener-Victorin E, Baghaei F, Holm G, Janson PO, Olivecrona G, Lönn M, et al., Effects of acupuncture and exercise on insulin sensitivity, adipose tissue characteristics, and markers of coagulation and fibrinolysis in women with polycystic ovary syndrome: secondary analyses of a randomized controlled trial. Fertility and Sterility 2012; 97 (2): 501 - 8. 10544627
15. Stener-Victorin E, Holm G, Janson PO, Gustafson D, Waern M,. Acupuncture and physical exercise for affective symptoms and health-related quality of life in polycystic ovary syndrome: secondary analysis from a randomized controlled trial. BMC Complementary and Alternative Medicine 2013; 13: 131. 10544628
16. Stener-Victorin E, Jedel E, Janson PO, Sverrisdottir YB,. Low-frequency electroacupuncture and physical exercise decrease high muscle sympathetic nerve activity in polycystic ovary syndrome. American Journal of Physiology - Regulatory, Integrative and Comparative Physiology 2009; 297 (2): R387 - 95. 10544629
17. Turan V, Mutlu EK, Solmaz U, Ekin A, Tosun O, Tosun G, et al., Benefits of short-term structured exercise in non-overweight women with polycystic ovary syndrome: a prospective randomised controlled study. Journal of Physical Therapy Science 2015; 27 (7): 2293 - 7. 10544631
18. Vigorito C, Giallauria F, Palomba S, Cascella T, Manguso F, Lucci R, et al., Beneficial effects of a three-month structured exercise training program on cardiopulmonary functional capacity in young women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2007; 92 (4): 1379 - 84. 3337405
19. Vizza L, Smith CA, Swaraj S, Agho K, Cheema BS,. The feasibility of progressive resistance training in women with polycystic ovary syndrome: a pilot randomised controlled trial. Sports Science, Medicine and Rehabilitation 2016; 8: 14. 10544633
20. Asemi Z, Esmaillzadeh A,. DASH diet, insulin resistance, and serum hs-CRP in polycystic ovary syndrome: a randomized controlled clinical trial. Hormone and Metabolic Research 2015; 47 (3): 232 - 8. 10544635
21. Atiomo W, Read A, Golding M, Silcocks P, Razali N, Sarkar S, et al., Local recruitment experience in a study comparing the effectiveness of a low glycaemic index diet with a low calorie healthy eating approach at achieving weight loss and reducing the risk of endometrial cancer in women with polycystic ovary syndrome (PCOS). Contemporary Clinical Trials 2009; 30 (5): 451 - 6. 10544637
22. Azadi-Yazdi M, Karimi-Zarchi M, Salehi-Abargouei A, Fallahzadeh H, Nadjarzadeh A,. Effects of Dietary Approach to Stop Hypertension diet on androgens, antioxidant status and body composition in overweight and obese women with polycystic ovary syndrome: a randomised controlled trial. Journal of Human Nutrition and Dietetics 2017; 30 (3): 275 - 83. 10544639
23. Beena MR, Thomas Kochuthressiamma,. Outcome of interventional programme on quality of life of infertile women with polycystic ovarian syndrome. International Journal of Nursing Education 2016; 8 (2): 27 - 33. 10544641
24. Bruner B, Chad K, Chizen D,. Effects of exercise and nutritional counseling in women with polycystic ovary syndrome. Applied Physiology, Nutrition, and Metabolism 2006; 31 (4): 384 - 91. 3337407
25. Curi DD, Fonseca AM, Marcondes JA, Almeida JA, Bagnoli VR, Soares JM Jr, et al., Metformin versus lifestyle changes in treating women with polycystic ovary syndrome. Gynecological Endocrinology 2012; 28 (3): 182 - 5. 10544643
26. Ebrahimi-Mamaghani M, Saghafi-Asl M, Pirouzpanah S, Asghari-Jafarabadi M,. Effects of raw red onion consumption on metabolic features in overweight or obese women with polycystic ovary syndrome: a randomized controlled clinical trial. Journal of Obstetrics and Gynaecology Research 2014; 40 (4): 1067 - 76. 10544645
27. Foroozanfard F, Rafiei H, Samimi M, Gilasi HR, Gorjizadeh R, Heidar Z, et al., The effects of dietary approaches to stop hypertension diet on weight loss, anti-Müllerian hormone and metabolic profiles in women with polycystic ovary syndrome: a randomized clinical trial. Clinical Endocrinology 2017; 87 (1): 51 - 8. 10544647
28. Fux Otta C, Wior M, Iraci GS, Kaplan R, Torres D, Gaido MI, et al., Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: a randomized, double-blind, and placebo control trial. Gynecological Endocrinology 2010; 26 (3): 173 - 8. 10544649
29. Giallauria F, Palomba S, Maresca L, Vuolo L, Tafuri D, Lombardi AM, et al., Exercise training improves autonomic function and inflammatory pattern in women with polycystic ovary syndrome. Clinical Endocrinology 2008; 69 (5): 792 - 8. 3337409
30. Glueck CJ, Aregawi D, Winiarska M, Agloria M, Luo G, Sieve L, et al., Metformin-diet ameliorates coronary heart disease risk factors and facilitates resumption of regular menses in adolescents with polycystic ovary syndrome. Journal of Pediatric Endocrinology and Metabolism 2006; 19 (6): 831 - 42. 3337411
31. Goss AM, Chandler-Laney PC, Ovalle F, Goree LL, Azziz R, Desmond RA, et al., Effects of a eucaloric reduced-carbohydrate diet on body composition and fat distribution in women with PCOS. Metabolism: Clinical & Experimental 2014; 63 (10): 1257 - 64. 10544651
32. Gower BA, Chandler-Laney PC, Ovalle F, Goree LL, Azziz R, Desmond RA, et al., Favourable metabolic effects of a eucaloric lower-carbohydrate diet in women with PCOS. Clinical Endocrinology 2013; 79 (4): 550 - 7. 10544652
33. Gower BA, Goss AM,. A lower-carbohydrate, higher-fat diet reduces abdominal and intermuscular fat and increases insulin sensitivity in adults at risk of type 2 diabetes. Journal of Nutrition 2015; 145 (1): 177S - 83S. 10544653
34. Hamayeli Mehrabani H, Tahbaz F, Salehpour S, Hedayati M, Amiri Z, Ghassemi A,. Reproductive hormonal changes following two types of hypocaloric diets in overweight and obese polycystic ovary syndrome women. Iranian Journal of Endocrinology and Metabolism 2010; 12 (2): 160 - 200. 10544655
35. Hutchison SK, Teede HJ, Rachon D, Harrison CL, Strauss BJ, Stepto NK,. Effect of exercise training on insulin sensitivity, mitochondria and computed tomography muscle attenuation in overweight women with and without polycystic ovary syndrome. Diabetologia 2012; 55 (5): 1424 - 34. 10544657
36. Jakubowicz D, Barnea M, Wainstein J, Froy O,. Effects of caloric intake timing on insulin resistance and hyperandrogenism in lean women with polycystic ovary syndrome. Clinical Science 2013; 125 (9): 423 - 32. 10544659
37. Jiskoot G, Benneheij SH, Beerthuizen A, de Niet JE, de Klerk C, Timman R, et al., A three-component cognitive behavioural lifestyle program for preconceptional weight-loss in women with polycystic ovary syndrome (PCOS): a protocol for a randomized controlled trial. Reproductive Health 2017; 14 (1): 34. 10544661
38. Johnson LK, Holven KB, Nordstrand N, Mellembakken JR, Tanbo T, Hjelmesæth J,. Fructose content of low calorie diets: effect on cardiometabolic risk factors in obese women with polycystic ovarian syndrome: a randomized controlled trial. Endocrine Connections 2015; 4 (3): 144 - 54. 10544663
39. Kim C, Pi-Sunyer X, Barrett-Connor E, Stentz FB, Murphy MB, Kong S, et al., Diabetes Prevention Program Research Group. Sex hormone binding globulin and sex steroids among premenopausal women in the diabetes prevention program. Journal of Clinical Endocrinology and Metabolism 2013; 98 (7): 3049 - 57. 10544665
40. Konopka AR, Asante A, Lanza IR, Robinson MM, Johnson ML, Dalla Man C, et al., Defects in mitochondrial efficiency and H2O2 emissions in obese women are restored to a lean phenotype with aerobic exercise training. Diabetes 2015; 64 (6): 2104 - 5. 10544667
41. Legro RS, Dodson WC, Kris-Etherton PM, Kunselman AR, Stetter CM, Williams NI, et al., Randomized controlled trial of preconception interventions in infertile women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2015; 100 (11): 4048 - 58. 10544669
42. Marzouk TM, Sayed Ahmed WA,. Effect of dietary weight loss on menstrual regularity in obese young adult women with polycystic ovary syndrome. Journal of Pediatric and Adolescent Gynecology 2015; 28 (6): 457 - 61. 10544671
43. Mehrabani HH, Salehpour S, Amiri Z, Farahani SJ, Meyer BJ, Tahbaz F,. Beneficial effects of a high-protein, low-glycemic-load hypocaloric diet in overweight and obese women with polycystic ovary syndrome: a randomized controlled intervention study. Journal of the American College of Nutrition 2012; 31 (2): 117 - 25. 10544673
44. Moran LJ, Noakes M, Clifton PM, Wittert GA, Williams G, Norman RJ,. Short-term meal replacements followed by dietary macronutrient restriction enhance weight loss in polycystic ovary syndrome. American Journal of Clinical Nutrition 2006; 84 (1): 77 - 87. 3337413
45. Moran LJ, Noakes M, Clifton PM, Norman RJ,. The effect of modifying dietary protein and carbohydrate in weight loss on arterial compliance and postprandial lipidemia in overweight women with polycystic ovary syndrome. Fertility and Sterility 2010; 94 (6): 2451 - 4. 10544675
46. Nidhi R, Padmalatha V, Nagarathna R, Amritanshu R,. Effect of holistic yoga program on anxiety symptoms in adolescent girls with polycystic ovarian syndrome: a randomized control trial. International Journal of Yoga 2012; 5 (2): 112 - 7. 10544677
47. Nybacka A, Carlstrom K, Fabri F, Hellstrom PM, Hirschberg AL,. Serum antimullerian hormone in response to dietary management and/or physical exercise in overweight/obese women with polycystic ovary syndrome: secondary analysis of a randomized controlled trial. Fertility and Sterility 2013; 100 (4): 1096 - 102. 10544679
48. Nybacka A, Carlstrom K, Stahle A, Nyren S, Hellstrom PM, Hirschberg AL,. Randomized comparison of the influence of dietary management and/or physical exercise on ovarian function and metabolic parameters in overweight women with polycystic ovary syndrome. Fertility & Sterility 2011; 96 (6): 1508 - 13. 10544680
49. Orio F, Giallauria F, Palomba S, Manguso F, Orio M, Tafuri D, et al., Metabolic and cardiopulmonary effects of detraining after a structured exercise training programme in young PCOS women. Clinical Endocrinology 2008; 68 (6): 976 - 81. 3337415
50. Orio F, Muscogiuri G, Giallauria F, Savastano S, Bottiglieri P, Tafuri D, et al., Oral contraceptives versus physical exercise on cardiovascular and metabolic risk factors in women with polycystic ovary syndrome: a randomized controlled trial. Clinical Endocrinology 2016; 85 (5): 764 - 71. 10544682
51. Ornstein RM, Copperman NM, Jacobson MS,. Effect of weight loss on menstrual function in adolescents with polycystic ovary syndrome. Journal of Pediatric & Adolescent Gynecology 2011; 24 (3): 161 - 5. 10544684
52. Palomba S, Giallauria F, Falbo A, Russo T, Oppedisano R, Tolino A, et al., Structured exercise training programme versus hypocaloric hyperproteic diet in obese polycystic ovary syndrome patients with anovulatory infertility: a 24-week pilot study. Human Reproduction 2008; 23 (3): 642 - 50. 3337417
53. Palomba S, Falbo A, Giallauria F, Russo T, Rocca M, Tolino A, et al., Six weeks of structured exercise training and hypocaloric diet increases the probability of ovulation after clomiphene citrate in overweight and obese patients with polycystic ovary syndrome: a randomized controlled trial. Human Reproduction 2010; 25 (11): 2783 - 91. 10544686
54. Panico A, Lupoli GA, Gelsy A, Cioffi, I, Zacchia, G, Caldara A, et al., Effects of an isocaloric low-glycemic-load diet in polycystic ovary syndrome. Nutritional Therapy & Metabolism 2014; 32 (2): 85 - 92. 10544688
55. Papakonstantinou E, Kechribari I, Mitrou P, Trakakis E, Vassiliadi D, Georgousopoulou E, et al., Effect of meal frequency on glucose and insulin levels in women with polycystic ovary syndrome: a randomised trial. European Journal of Clinical Nutrition 2016; 70 (5): 588 - 94. 10544690
56. Pasquali R, Fabbri R, Venturoli S, Paradisi R, Antenucci D, Melchionda N,. Effect of weight loss and antiandrogenic therapy on sex hormone blood levels and insulin resistance in obese patients with polycystic ovaries. American Journal of Obstetrics and Gynecology 1986; 154 (1): 139 - 44. 3337419
57. Pasquali R, Gambineri A, Biscotti D, Vicennati V, Gagliardi L, Colitta D, et al., Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2000; 85 (8): 2767 - 74. 3337421
58. Pekhlivanov B, Mitkov M, Kavurdzhikova S,. Clinical, hormonal and biochemical changes after treatment with metformin and weight reduction in women with polycystic ovary syndrome. Akusherstvo i Ginekologiia 2006; 45 (6): 29 - 35. 3337423
59. Roessler KK, Birkebaek C, Ravn P, Andersen MS, Glintborg D,. Effects of exercise and group counselling on body composition and VO2max in overweight women with polycystic ovary syndrome. Acta Obstetricia et Gynecologica Scandinavica 2013; 92 (3): 272 - 7. 10544692
60. J Sá JC, Costa EC, da Silva E, Tamburús NY, Porta A, Medeiros LF, et al., Aerobic exercise improves cardiac autonomic modulation in women with polycystic ovary syndrome. International Journal of Cardiology 2016; 202: 356 - 61. 10544694
61. Sordia-Hernández LH, Ancer Rodríguez P, Saldivar Rodriguez D, Trejo Guzman S, Servín Zenteno ES, Guerrero González G, et al., Effect of a low glycemic diet in patients with polycystic ovary syndrome and anovulation - a randomized controlled trial. Clinical and Experimental Obstetrics & Gynecology 2016; 43 (4): 555 - 9. 10544696
62. Sørensen LB, Søe M, Halkier KH, Stigsby B, Astrup A,. Effects of increased dietary protein-to-carbohydrate ratios in women with polycystic ovary syndrome. American Journal of Clinical Nutrition 2012; 95 (1): 39 - 48. 10544698
63. Sprung VS, Cuthbertson DJ, Pugh CJ, Aziz N, Kemp GJ, Daousi C, et al., Exercise training in polycystic ovarian syndrome enhances flow-mediated dilation in the absence of changes in fatness. Medicine and Science in Sports and Exercise 2013; 45 (12): 2234 - 42. 10544700
64. Talluto C,. The effects of a six-week aerobic and weight-resistance training program on infertility patients diagnosed with polycystic ovary syndrome. Fertility and Sterility 2002; 78 Suppl 1 (3): 152. 3337425
65. Tang T, Glanville J, Hayden CJ, White D, Barth JH, Balen AH,. Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study. Human Reproduction 2006; 21 (1): 80 - 9. 3337427
66. Thomson RL, Buckley JD, Noakes M, Clifton PM, Norman RJ, Brinkworth GD,. The effect of a hypocaloric diet with and without exercise training on body composition, cardiometabolic risk profile, and reproductive function in overweight and obese women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2008; 93 (9): 3373 - 80. 3337429
67. Thomson RL, Buckley JD, Brinkworth GD,. Perceived exercise barriers are reduced and benefits are improved with lifestyle modification in overweight and obese women with polycystic ovary syndrome: a randomised controlled trial. BMC Women's Health 2016; 16: 14. 10544702
68. Toscani MK, Mario FM, Radavelli-Bagatini S, Wiltgen D, Matos MC, Spritzer PM,. Effect of high-protein or normal-protein diet on weight loss, body composition, hormone, and metabolic profile in southern Brazilian women with polycystic ovary syndrome: a randomized study. Gynecological Endocrinology 2011; 27 (11): 925 - 30. 10544704
69. Turner-McGrievy GM, Davidson CR, Wingard EE, Billings DL,. Low glycemic index vegan or low-calorie weight loss diets for women with polycystic ovary syndrome: a randomized controlled feasibility study. Nutrition Research 2014; 34 (6): 552 - 8. 10544706
70. Wong JM, Gallagher M, Gooding H, Feldman HA, Gordon CM, Ludwig DS, et al., A randomized pilot study of dietary treatments for polycystic ovary syndrome in adolescents. Pediatric Obesity 2016; 11 (3): 210 - 20. 10544708
71. Zarrinkoub F, Beigi A,. Insulin-sensitization versus lifestyle modification in the management of adolescent girls with polycystic ovary syndrome. The 21st Annual Meeting of the European Society of Human Reproduction and Embryology. 2005. 3337431
72. Gaeini AA, Satarifard S, Mohamadi F, Rajaei M,. The effect of a twelve-weeks aerobic exercise on ovarian androgens and body composition of women with polycystic ovary syndrome. Armaghane Danesh Journal 2012; 17 (5): 387 - 97. 10544710
73. Acien P, Quereda F, Matallin P, Villarroya E, Lopez-Fernandez JA, Acien M, et al., Insulin, androgens, and obesity in women with and without polycystic ovary syndrome: a heterogeneous group of disorders. Fertility and Sterility 1999; 72: 32 - 40.
74. Alebić MŠ, Bulum T, Stojanović N, Duvnjak L,. Definition of insulin resistance using the homeostasis model assessment (HOMA-IR) in IVF patients diagnosed with polycystic ovary syndrome (PCOS) according to the Rotterdam criteria. Endocrine 2014; 47 (2): 625 - 30.
75. Androulakis II, Kandaraki E, Christakou C, Karachalios A, Marinakis E, Paterakis T, et al., Visceral adiposity index (VAI) is related to the severity of anovulation and other clinical features in women with polycystic ovary syndrome. Clinical Endocrinology 2014; 81 (3): 426 - 31.
76. Aziz Z, Absetz P, Oldroyd J, Pronk NP, Oldenburg B,. A systematic review of real-world diabetes prevention programs: learnings from the last 15 years. Implementation Science 2015; 15 (10): 172.
77. Balen AH, Conway GS, Kaltsas G, Techatrasak K, Manning PJ, West C, et al., Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Human Reproduction 1995; 10: 2107 - 11.
78. Barbieri RL, Makris A, Randall RW, Daniels G, Kistner RW, Ryan KJ,. Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism. Journal of Clinical Endocrinology and Metabolism 1986; 62: 904 - 10.
79. Behboudi-Gandevani S, Ramezani Tehrani F, Rostami Dovom M, Farahmand M, Bahri Khomami M, Noroozzadeh M, et al., Insulin resistance in obesity and polycystic ovary syndrome: systematic review and meta-analysis of observational studies. Gynecological Endocrinology 2016; 32 (5): 343 - 53.
80. Benham JL, Yamamoto JM, Friedenreich CM, Rabi DM, Sigal RJ,. Role of exercise training in polycystic ovary syndrome: a systematic review and meta-analysis. Clinical Obesity 2018; 8 (4): 275 - 84.
81. Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO,. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Human Reproduction 2016; 31 (12): 2841 - 55.
82. Clark AM, Thornley B, Tomlinson L, Galletley C, Norman RJ,. Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment. Human Reproduction 1998; 13: 1502 - 5.
83. Daan NM, Louwers YV, Koster MP, Eijkemans MJ, de Rijke YB, Lentjes EW, et al., Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk?. Fertility and Sterility 2014; 102: 1444 - 51.
84. DeUgarte CM, Bartolucci AA, Azziz R,. Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. Fertility and Sterility 2005; 83: 1454 - 60.
85. Domecq JP, Prutsky G, Mullan RJ, Hazem A, Sundaresh V, Elamin MB, et al., Lifestyle modification programs in polycystic ovary syndrome: systematic review and meta-analysis. Journal of Clinical Endocrinology and Metabolism 2013; 98 (12): 4655 - 63.
86. Ehrmann DA, Liljenquist DR, Kasza K, Azziz R, Legro RS, Ghazzi MN, et al., Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2006; 91: 48 - 53.
87. ESHRE/ASRM,. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility and Sterility 2004; 81: 19 - 25.
88. Essah PA, Nestler JE, Carmina E,. Differences in dyslipidemia between American and Italian women with polycystic ovary syndrome. Journal of Endocrinological Investigation 2008; 31: 35 - 41.
89. McMaster University, developed by Evidence Prime, Inc. GRADEpro GDT: GRADEpro Guideline Development Tool. McMaster University, developed by Evidence Prime, Inc., 2015.
90. Gunning MN, Fauser BCJM,. Are women with polycystic ovary syndrome at increased cardiovascular disease risk later in life?. Climacteric 2017; 20 (3): 222 - 7.
91. Haqq L, McFarlane J, Dieberg G, Smart N,. Effect of lifestyle intervention on the reproductive endocrine profile in women with polycystic ovarian syndrome: a systematic review and meta-analysis. Endocrine Connections 2014; 3 (1): 36 - 46.
92. Haqq L, McFarlane J, Dieberg G, Smart N,. The effect of lifestyle intervention on body composition, glycemic control, and cardiorespiratory fitness in polycystic ovarian syndrome: a systematic review and meta-analysis. International Journal of Sport Nutrition and Exercise Metabolism 2015; 25 (6): 533 - 40.
93. Heida KY, Bots ML, de Groot CJ, van Dunné FM, Hammoud NM, Hoek A, et al., Cardiovascular risk management after reproductive and pregnancy-related disorders: a Dutch multidisciplinary evidence-based guideline. European Journal of Preventive Cardiology 2016; 17: 1863 - 79.
94. Higgins JPT, Green S (editors),. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
95. Huber-Buchholz MM, Carey DG, Norman RJ,. Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone. Journal of Clinical Endocrinology and Metabolism 1999; 84: 1470 - 4.
96. Hutchison SK, Stepto NK, Harrison CL, Moran LJ, Strauss BJ, Teede HJ,. Effects of exercise on insulin resistance and body composition in overweight and obese women with and without polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2011; 96 (1): E48 - 56.
97. Teede H, Misso M, Costello M, Dokras A, Laven J, Moran L, et al on behalf of the International PCOS Network. International evidence based guideline for the assessment and management of polycystic ovary syndrome. https://www.monash.edu/-data/assets/pdf-file/0004/1412644/PCOS-Evidence-Based-Guidelines-20181009.pdf 2018.
98. Jedel E, Labrie F, Oden A, Holm G, Nilsson L, Janson PO, et al., Impact of electro-acupuncture and physical exercise on hyperandrogenism and oligo/amenorrhea in women with polycystic ovary syndrome: a randomised controlled trial. American Journal of Physiology-Endocrinology and Metabolism 2011; 300 (1): E37 - 45.
99. Kakoly NS, Khomami MB, Joham AE, Cooray SD, Misso ML, Norman RJ, et al., Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression. Human Reproduction Update 2018; 24 (4): 455 - 67.
100. Kiddy DS, Sharp PS, White DM, Scanlon MF, Mason HD, Bray CS, et al., Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases. Clinical Endocrinology 1990; 32: 213 - 20.
101. Landay M, Huang A, Azziz R,. Degree of hyperinsulinemia, independent of androgen levels, is an important determinant of the severity of hirsutism in PCOS. Fertility and Sterility 2009; 92 (2): 643 - 7.
102. Lass N, Kleber M, Winkel K, Wunsch R, Reinehr T,. Effect of lifestyle intervention on features of polycystic ovarian syndrome, metabolic syndrome, and intima-media thickness in obese adolescent girls. Journal of Clinical Endocrinology and Metabolism 2011; 96 (11): 3533 - 40.
103. Legro RS, Kunselman AR, Dodson WC, Dunaif A,. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. Journal of Clinical Endocrinology and Metabolism 1999; 84: 165 - 9.
104. Leonhardt H, Hellstrom M, Gull B, Lind AK, Nilsson L, Janson OP, et al., Serum anti-Mullerian hormone and ovarian morphology assessed by magnetic resonance imaging in response to acupuncture and exercise in women with polycystic ovary syndrome: secondary analyses of a randomized controlled trial. Acta Obstetricia et Gynecologica Scandinavica 2015; 94: 279 - 87.
105. Lim SS, Davies MJ, Norman RJ, Moran LJ,. Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Human Reproduction Update 2012; 18 (6): 618 - 37.
106. Lim SS, Norman RJ, Davies MJ, Moran LJ,. The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis. Obesity Reviews 2013; 14 (2): 95 - 109.
107. Lønnebotn M, Natvig GK, Benediktsdóttir B, Burgess JA, Holm M, Jógi R, et al., Polycystic ovary syndrome, body mass index and hypertensive disorders in pregnancy. Pregnancy Hypertension 2018; 11: 32 - 7.
108. March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ,. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Human Reproduction 2010; 25 (2): 544 - 51.
109. Meyer C, McGrath BP, Teede HJ,. Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease. Journal of Clinical Endocrinology and Metabolism 2005; 90: 5711 - 6.
110. Moran LJ, Noakes M, Clifton PM, Tomlinson L, Norman RJ,. Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2003; 88: 812 - 9.
111. Moran LJ, Pasquali R, Teede HJ, Hoeger KM, Norman RJ,. Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society. Fertility and Sterility 2009; 92 (6): 1966 - 82.
112. Moran L, Teede H,. Metabolic features of the reproductive phenotypes of polycystic ovary syndrome. Human Reproduction Update 2009; 15 (4): 477 - 88.
113. Moran LJ, Misso M, WIld RA, Norman RJ,. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: A systematic review and meta-analysis. Human Reproduction Update 2010; 16 (4): 347 - 63.
114. Morley LC, Tang T, Yasmin E, Norman RJ, Balen AH,. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database of Systematic Reviews 2017, Issue 11. [DOI: 10.1002/14651858.CD003053.pub6 ]
115. Naderpoor N, Shorakae S, de Courten B, Misso ML, Moran LJ, Teede HJ,. Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis. Human Reproduction Update 2015; 21 (5): 560 - 74.
116. Paradisi G, Steinberg HO, Hempfling A, Cronin J, Hook G, Shepard MK, et al., Polycystic ovary syndrome is associated with endothelial dysfunction. Circulation 2001; 103: 1410 - 5.
117. Plymate SR, Matej LA, Jones RE, Friedl KE,. Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin. Journal of Clinical Endocrinology and Metabolism 1988; 67: 460 - 4.
118. Poehlman ET, Dvorak RV, DeNino WF, Brochu M, Ades PA,. Effects of resistance training and endurance training on insulin sensitivity in nonobese, young women: a controlled randomized trial. Journal of Clinical Endocrinology and Metabolism 2000; 85: 2463 - 8.
119. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
120. Richards J, Jiang X, Kelly P, Chau J, Bauman A, Ding D,. Don't worry, be happy: cross-sectional associations between physical activity and happiness in 15 European countries. BMC Public Health 2015; 15: 53.
121. Roberts CK, Little JP, Thyfault JP,. Modification of insulin sensitivity and glycemic control by activity and exercise. Medicine & Science in Sports & Exercise 2013; 45 (10): 1868 - 77.
122. Ross R, Dagnone D, Jones PJ, Smith H, Paddags A, Hudson R, et al., Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial. Annals of Internal Medicine 2000; 133: 92 - 103.
123. Rubin KH, Glintborg D, Nybo M, Abrahamsen B, Andersen M,. Development and risk factors of type 2 diabetes in a nationwide population of women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2017; 102 (10): 3848 - 57.
124. Salazar MR, Carbajal HA, Espeche WG, Aizpurúa M, Leiva Sisnieguez CE, Leiva Sisnieguez BC, et al., Insulin resistance: the linchpin between prediabetes and cardiovascular disease. Diabetes & Vascular Disease Research 2016; 13 (2): 157 - 63.
125. Stener-Victorin E, Jedel E, Janson PO, Sverrisdottir YB,. Low-frequency electroacupuncture and physical exercise decrease high muscle sympathetic nerve activity in polycystic ovary syndrome. American Journal of Physiology - Regulatory, Integrative and Comparative Physiology 2009; 297 (2): R387 - 95. 3337403
126. Stener-Victorin E, Baghaei F, Holm G, Janson PO, Olivecrona G, Lönn M, Manners-Holm L,. Effects of acupuncture and exercise on insulin sensitivity, adipose tissue characteristics, and markers of coagulation and fibrinolysis in women with polycystic ovary syndrome: secondary analyses of a randomized controlled trial. Fertility and Sterility 2012; 97 (2): 501 - 8.
127. Stener-Victorin E, Holm G, Janson PO, Gustafson D, Waern M,. Acupuncture and physical exercise for affective symptoms and health-related quality of life in polycystic ovary syndrome: secondary analysis from a randomized controlled trial. BMC Complementary and Alternative Medicine 2013; 13: 131.
128. Stepto NK, Cassar S, Joham AE, Hutchison SK, Harrison CL, Goldstein RF, et al., Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp. Human Reproduction 2013; 28 (3): 777 - 84.
129. Teede H, Hutchison SK, Zoungas S,. The management of insulin resistance in polycystic ovary syndrome. Trends in Endocrinology and Metabolism 2007; 18 (7): 273 - 9.
130. Teede HJ, Misso ML, Deeks AA, Moran LJ, Stuckey BG, Wong JL, et al., Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline. Medical Journal of Australia 2011; 195 (6): S65 - 112.
131. Vrbikova J, Hill M, Fanta M,. The utility of fasting plasma glucose to identify impaired glucose metabolism in women with polycystic ovary syndrome. Gynecological Endocrinology 2014; 30 (9): 664 - 6.
132. Yang R, Yang S, Li R, Liu P, Qiao J, Zhang Y,. Effects of hyperandrogenism on metabolic abnormalities in patients with polycystic ovary syndrome: a meta-analysis. Reproductive Biology and Endocrinology 2016; 14 (1): 67.
133. Zawadski J, Dunaif A,. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. Polycystic Ovary Syndrome Current Issues in Endocrinology and Metabolism. Boston: Blackwell Scientific, 1992: 377 - 84.
134. Moran LJ, Hutchison SK, Norman RJ, Teede HJ,. Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database of Systematic Reviews 2011, Issue 7. [DOI: 10.1002/14651858.CD007506.pub3 ]